Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2026-02-10
DOI
https://doi.org/10.1172/jci201762
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma

Daniel J. Schaid, Carolin Victoria Schneider, Lorenzo Miano, Mirella Fraquelli et al.
Journal of Clinical Investigation
Liver Disease Diagnosis and Treatment
article

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma

Daniel J. Schaid, Carolin Victoria Schneider, Lorenzo Miano, Mirella Fraquelli, Marco Saracino, Rosellina Margherita Mancina, Vincenzo La Mura, Matteo Mureddu, Hadi Eidgah Torghabehei, Daniele Prati, Luisa Ronzoni, Luca Miele, Roberta D'Ambrosio, Robertino Dilena, Oveis Jamialahmadi, Vittoria Moretti, Julie A. Lynch, Josephine P. Johnson, Saleh A. Alqahtani, Giulia Periti, Salvatore Petta, Serena Pelusi, Stefano Romeo, Elisabetta Bugianesi, Francesco Paolo Russo, Paolo Parini, Alessandro Cherubini, Francesco Malvestiti, Luca V.C. Valenti, Kyong-Mi Chang
article en

Abstract

No abstract available for this paper.
Journal of Clinical Investigation
Karolinska University Hospital (SE), University of Padua (IT), Università Campus Bio-Medico (IT), VA Palo Alto Health Care System (US), University of Pavia (IT), King Faisal Specialist Hospital & Research Centre (SA), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), VA Salt Lake City Healthcare System (US), University of Palermo (AR), University of Pennsylvania (US), University of Gothenburg (SE), RWTH Aachen University (DE), University of Palermo (IT)
U.S. Department of Veterans Affairs, Amgen, Pfizer, AstraZeneca, Sanofi, Office of Research and Development, Celgene, Ultragenyx Pharmaceutical, European Commission, Ministero della Salute, Novo Nordisk, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, National Institutes of Health, Horizon 2020 Framework Programme
Good health and well-being
Openalex Percentile: Top 60%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.